ESR1 and breast cancer: The [18F]-FES uptake in healthy liver tissue of patients with ER+ tumors in our study was similar to other studies in patients with (suspected) ER+ breast cancer (median SUVmax 15.4, range: 12.5–18.7; median SUVmean 12, IQR: 10–14) [19,23,24].